Artículos de revistas sobre el tema "MUTANT SCORE"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "MUTANT SCORE".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Xie, Yuancai, Yingmei Li, Linfeng Dong, Shifu Chen y Jixian Liu. "A differential analysis of TCR repertoire between patients with EGFR-mutant and KRAS-mutant non–small-cell lung cancer." Journal of Clinical Oncology 41, n.º 16_suppl (1 de junio de 2023): e21012-e21012. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e21012.
Texto completoSugave, Shounak Rushikesh, Yogesh R. Kulkarni y Balaso. "Multi-Objective Optimization Model and Hierarchical Attention Networks for Mutation Testing". International Journal of Swarm Intelligence Research 14, n.º 1 (9 de marzo de 2023): 1–23. http://dx.doi.org/10.4018/ijsir.319714.
Texto completoKarsy, Michael, Jian Guan y L. Eric Huang. "Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase–mutant glioma". Journal of Neurosurgery 130, n.º 1 (marzo de 2018): 56–66. http://dx.doi.org/10.3171/2017.9.jns172036.
Texto completoAlmahasheer, Arwa Ali, Amal Mahmoud, Hesham El-Komy, Amany I. Alqosaibi, Sultan Aktar, Sayed AbdulAzeez y J. Francis Borgio. "Novel Feather Degrading Keratinases from Bacillus cereus Group: Biochemical, Genetic and Bioinformatics Analysis". Microorganisms 10, n.º 1 (1 de enero de 2022): 93. http://dx.doi.org/10.3390/microorganisms10010093.
Texto completoYu, Guangyang, Ying Pang, Mythili Merchant, Chimene Kesserwan, Vineela Gangalapudi, Abdalla Abdelmaksoud, Alice Ranjan et al. "Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas". Cancers 13, n.º 23 (3 de diciembre de 2021): 6092. http://dx.doi.org/10.3390/cancers13236092.
Texto completoGuimarães-Souza, Nadia Karina, Liliya Marsovna Yamaleyeva, Baisong Lu, Ana Claudia Mallet de Souza Ramos, Colin Edward Bishop y Karl Erik Andersson. "Superoxide overproduction and kidney fibrosis: a new animal model". Einstein (São Paulo) 13, n.º 1 (marzo de 2015): 79–88. http://dx.doi.org/10.1590/s1679-45082015ao3179.
Texto completoYeatman, Timothy Joseph, Mingli Yang, Michael J. Schell, Andrey Loboda, Michael Nebozhyn, Jiannong Li, Jamie K. Teer, Caio Max S. Rocha Lima y Jack Pledger. "Identification of mutation biomarkers underpinning colon cancer sidedness and cetuximab sensitivity." Journal of Clinical Oncology 36, n.º 4_suppl (1 de febrero de 2018): 629. http://dx.doi.org/10.1200/jco.2018.36.4_suppl.629.
Texto completoHe, Qiong, Yamin Li, Xihong Zhou, Wen Zhou, Chunfang Xia, Ruzhe Zhang, Zhengjie Zhang, Aiyang Hu, Siyin Peng y Jing Li. "The combination of fibrinogen concentrations and the platelet-to-lymphocyte ratio predicts survival in patients with advanced lung adenocarcinoma treated with EGFR-TKIs". Journal of International Medical Research 49, n.º 4 (abril de 2021): 030006052110040. http://dx.doi.org/10.1177/03000605211004021.
Texto completoBoucai, Laura, Venkatraman Seshan, Michelle Williams, Jeffrey A. Knauf, Mahesh Saqcena, Ronald A. Ghossein y James A. Fagin. "Characterization of Subtypes of BRAF-Mutant Papillary Thyroid Cancer Defined by Their Thyroid Differentiation Score". Journal of Clinical Endocrinology & Metabolism 107, n.º 4 (23 de noviembre de 2021): 1030–39. http://dx.doi.org/10.1210/clinem/dgab851.
Texto completoHannaway, Nicola, Stefania Kassaris, Janine Marie Davies, Alannah Smrke, Anna Tinker y Yvette Drew. "Using chemotherapy response by KELIM score to predict response to first line maintenance PARP inhibitor therapy in non-BRCA mutant/homologous recombination deficiency (HRD) unknown high grade serous ovarian cancer (HGSOC)." Journal of Clinical Oncology 41, n.º 16_suppl (1 de junio de 2023): e17547-e17547. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e17547.
Texto completoSaw, Stephanie, Gillianne Lai, Aaron C. Tan, Siqin Zhou, Mei-Kim Ang, Wan-Teck Lim, Ravindran Kanesvaran et al. "PD-L1 score as a prognostic biomarker in Asian patients with early-stage, EGFR-mutated lung cancer." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junio de 2022): 8527. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.8527.
Texto completoDelorenzi, Mauro, Sarah Gerster, Josep Tabernero, Claus-Henning Köhne, Peter J. O'Dwyer, Alberto F. Sobrero, Eric van Cutsem et al. "Microarray gene expression study of the RESPECT trial for the identification of prognostic and predictive markers." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): e14561-e14561. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e14561.
Texto completoMontégut, Coline, Jean-Sébastien Guillamo, François Ducray, Caroline Dehais, Cohen-Jonathan Moyal Elisabeth, Christine Desenclos, Antoine Petit et al. "NCOG-09. PREDICTIVE GERIATRIC FACTORS IN ELDERLY PATIENTS TREATED FOR IDH-MUTANT HIGH-GRADE GLIOMAS: A FRENCH POLA NETWORK STUDY". Neuro-Oncology 23, Supplement_6 (2 de noviembre de 2021): vi153. http://dx.doi.org/10.1093/neuonc/noab196.600.
Texto completoMiyawaki, Eriko, Haruyasu Murakami, Keita Mori, Nobuaki Mamesaya, Takahisa Kawamura, Haruki Kobayashi, Shota Omori et al. "PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer". Japanese Journal of Clinical Oncology 50, n.º 5 (25 de marzo de 2020): 617–22. http://dx.doi.org/10.1093/jjco/hyaa033.
Texto completoAdderley, Helen M., Mihaela Aldea, Jaqueline Aredo, Mathew Carter, Matthew Church, Pantelis Nicola, Jamie Weaver et al. "Abstract 2975: RAS precision medicine transatlantic partnership: Exploration of RAS and NF1 co-mutations in NSCLC". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 2975. http://dx.doi.org/10.1158/1538-7445.am2022-2975.
Texto completoMasoodi, Tariq Ahmad, Sulaiman A. Al Shammari, May N. Al-Muammar y Adel A. Alhamdan. "Screening and Evaluation of Deleterious SNPs in APOE Gene of Alzheimer’s Disease". Neurology Research International 2012 (2012): 1–8. http://dx.doi.org/10.1155/2012/480609.
Texto completoPoon, CC, P. Gordon, K. Liu, R. Yang, S. Sarkar, VW Yong y J. Kelly. "GP.06 Differential microglia and macrophage profiles in human IDH-mutant and -wildtype glioblastoma reveal therapeutic vulnerabilities". Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 46, s1 (junio de 2019): S7. http://dx.doi.org/10.1017/cjn.2019.82.
Texto completoHide, Takuichiro, Jun Hatakeyama, Chiharu Kimura-Yoshida, E. Tian, Naoki Takeda, Yukitaka Ushio, Toshihiko Shiroishi, Shinichi Aizawa y Isao Matsuo. "Genetic modifiers of otocephalic phenotypes inOtx2heterozygous mutant mice". Development 129, n.º 18 (15 de septiembre de 2002): 4347–57. http://dx.doi.org/10.1242/dev.129.18.4347.
Texto completoOklejewicz, Małgorzata, Serge Daan, Eddy Van Der Zee y Menno Gerkema. "MEMORY RETENTION IN WILD-TYPE AND TAU MUTANT SYRIAN HAMSTERS". Behaviour 138, n.º 6 (2001): 789–96. http://dx.doi.org/10.1163/156853901752233415.
Texto completoKakar, Kifayatullah, Tran Dang Xuan, Nguyen Van Quan, Imran Khan Wafa, Hoang-Dung Tran, Tran Dang Khanh y Tran Dang Dat. "Efficacy of N-methyl-N-nitrosourea (MNU) Mutation on Enhancing the Yield and Quality of Rice". Agriculture 9, n.º 10 (27 de septiembre de 2019): 212. http://dx.doi.org/10.3390/agriculture9100212.
Texto completoYan, Dong, Lixin Sun, Jiandong Yang, Xuyang Zhang, Xia You, Tingting Sun y Chuang Qi. "Prognostic values of immune landscape in Ras-mutant colorectal cancer peritoneal metastases." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junio de 2022): e15583-e15583. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e15583.
Texto completoYan, Dong, Lixin Sun, Jiandong Yang, Xuyang Zhang, Xia You, Tingting Sun y Chuang Qi. "Prognostic values of immune landscape in Ras-mutant colorectal cancer peritoneal metastases." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junio de 2022): e15583-e15583. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e15583.
Texto completoDao Trong, Philip, Saskia Rösch, Heimo Mairbäurl, Stefan Pusch, Andreas Unterberg, Christel Herold-Mende y Rolf Warta. "Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma". International Journal of Molecular Sciences 19, n.º 10 (25 de septiembre de 2018): 2903. http://dx.doi.org/10.3390/ijms19102903.
Texto completoMartinez Lago, Nieves, Marta Covela Rúa, Elena Brozos, Ana Fernandez Montes, Juan de La Camara Gomez, Carlos Méndez Méndez, Mónica Jorge Fernández y Antia Cousillas Castiñeira. "The role of Systemic Inflammation Score (SIS) in BRAF(V600) mutant metastatic colorectal cancer (mCRC)." Journal of Clinical Oncology 38, n.º 15_suppl (20 de mayo de 2020): e16051-e16051. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e16051.
Texto completoJacobsen, Ilse, Isabel Hennig-Pauka, Nina Baltes, Matthias Trost y Gerald-F. Gerlach. "Enzymes Involved in Anaerobic Respiration Appear To Play a Role in Actinobacillus pleuropneumoniae Virulence". Infection and Immunity 73, n.º 1 (enero de 2005): 226–34. http://dx.doi.org/10.1128/iai.73.1.226-234.2005.
Texto completoRandall, Jamie, Hongkun Wang, Sheryl Krevsky Elkin, Gail Payne, Sarah Mullaly, Erica Marchlik, Dan Barnett et al. "Targetable mutations in gastrointestinal malignancies: A comparison of RAS mutant and RAS wild type tumors." Journal of Clinical Oncology 39, n.º 3_suppl (20 de enero de 2021): 129. http://dx.doi.org/10.1200/jco.2021.39.3_suppl.129.
Texto completoDzambazovska-Trajkovska, Vanja, Jordan Nojkov, Andrijan Kartalov, Biljana Kuzmanovska, Tatjana Spiroska, Redzep Seljmani, Gjorgji Trajkovski, Nadica Matevska-Geshkovska y Aleksandar Dimovski. "Association of Single-Nucleotide Polymorhism C3435T in the ABCB1 Gene with Opioid Sensitivity in Treatment of Postoperative Pain". PRILOZI 37, n.º 2-3 (1 de noviembre de 2016): 73–80. http://dx.doi.org/10.1515/prilozi-2016-0019.
Texto completoBerzero, Giulia, Luisa Bellu, Capucine Baldini, François Ducray, David Guyon, Marica Eoli, Antonio Silvani et al. "Sustained Tumor Control With MAPK Inhibition in BRAF V600–Mutant Adult Glial and Glioneuronal Tumors". Neurology 97, n.º 7 (4 de junio de 2021): e673-e683. http://dx.doi.org/10.1212/wnl.0000000000012330.
Texto completoDorta Suarez, M., B. Jimenez Munarriz, A. Del Barrio, G. Garcia Ledo, R. Blanco Blanco, E. Conde Gallego, S. Hernandez Prieto, F. Lopez Rios y A. Cubillo Gracián. "12P Molecular features of KRAS mutant NSCLC: Weaving a future score for immune-checkpoint inhibitors (ICI)". Annals of Oncology 32 (octubre de 2021): S1349. http://dx.doi.org/10.1016/j.annonc.2021.08.2008.
Texto completoSchneider, Friederike, Annika Dufour, Tobias Benthaus, Stephanie Schneider, Gudrun Mellert, Evelyn Zellmeier, Stefan K. Bohlander et al. "A New Molecular and Clinical Prognostic Score for Risk Stratification in CN-AML." Blood 114, n.º 22 (20 de noviembre de 2009): 2635. http://dx.doi.org/10.1182/blood.v114.22.2635.2635.
Texto completoBurgess, Brian T., Abigail M. Anderson, J. Robert McCorkle, Jianrong Wu, Frederick R. Ueland y Jill M. Kolesar. "Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells". Diagnostics 10, n.º 2 (22 de febrero de 2020): 121. http://dx.doi.org/10.3390/diagnostics10020121.
Texto completoRothermel, Luke Daniel, Mehrdad Zarei, Alexander W. Loftus, Jonathan J. Hue, Omid Hajihassani, Hallie J. Graor y Jordan Michael Winter. "A powerful drug combination strategy targeting BRAF-mutant melanoma." Journal of Clinical Oncology 41, n.º 16_suppl (1 de junio de 2023): 3152. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.3152.
Texto completoMoorman, Nathaniel J., Chie Yu Lin y Samuel H. Speck. "Identification of Candidate Gammaherpesvirus 68 Genes Required for Virus Replication by Signature-Tagged Transposon Mutagenesis". Journal of Virology 78, n.º 19 (1 de octubre de 2004): 10282–90. http://dx.doi.org/10.1128/jvi.78.19.10282-10290.2004.
Texto completoTan, Lili, Yunzhan Gong y Yawen Wang. "A Model for Predicting Statement Mutation Scores". Mathematics 7, n.º 9 (23 de agosto de 2019): 778. http://dx.doi.org/10.3390/math7090778.
Texto completoKeshtvarz, Maryam, Mahdieh Mahboobi, Marek Kieliszek, Antoni Miecznikowski, Hamid Sedighian, Milad Rezaei, Mohammad Ali Haghighi, Zahra Zareh y Ehsan Rezaei. "Engineering of Cytolethal Distending Toxin B by Its Reducing Immunogenicity and Maintaining Stability as a New Drug Candidate for Tumor Therapy; an In Silico Study". Toxins 13, n.º 11 (5 de noviembre de 2021): 785. http://dx.doi.org/10.3390/toxins13110785.
Texto completoDoubleday, Kevin, Daniel Gaile, Ravi Vijaya-Satya, Xianxian Liu, Kevin D'Auria, Soni Shukla, Han-Yu Chuang, Katie Quinn y Darya Chudova. "Abstract 5015: Precision profile simulation study for a next generation sequencing bTMB assay". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 5015. http://dx.doi.org/10.1158/1538-7445.am2022-5015.
Texto completoEl Baiomy, Mohamed Ali, Salah Aref y Mohamed El-Ghonemy. "Influence of CYP3A5 and SLCO1 on Imatinib Response Among Egyptian Patients with Chronic Myeloid Leukemia in Chronic Phase". Blood 128, n.º 22 (2 de diciembre de 2016): 5135. http://dx.doi.org/10.1182/blood.v128.22.5135.5135.
Texto completoChandler, David, Sash Lopaticki, Dexing Huang, Michael Hunter, Dora Angelicheva, Trevor Kilpatrick, Rosalind HM King, Luba Kalaydjieva y Grant Morahan. "The stretcher spontaneous neurodegenerative mutation models Charcot-Marie-Tooth disease type 4D". F1000Research 2 (13 de febrero de 2013): 46. http://dx.doi.org/10.12688/f1000research.2-46.v1.
Texto completoRamadhan, Dwi Syah Fitra y Daryono H. Tjahjono. "Prediksi dan Identifikasi Struktur Protein EGFR Kanker Paru dengan Mutasi Titik L718Q/T790M Secara Pemodelan Homologi In Silico". Jurnal Sains dan Kesehatan 2, n.º 4 (31 de diciembre de 2020): 491–96. http://dx.doi.org/10.25026/jsk.v2i4.257.
Texto completoJohansson, Elinn y Alexander Pietras. "CSIG-11. HYPOXIA SIGNALING IN ACVR1-MUTANT DIFFUSE INTRINSIC PONTINE GLIOMA". Neuro-Oncology 24, Supplement_7 (1 de noviembre de 2022): vii41. http://dx.doi.org/10.1093/neuonc/noac209.160.
Texto completoGómez-Almería, Marta, Sonia Burgaz, Carlos Costas-Insua, Carmen Rodríguez-Cueto, Irene Santos-García, Ignacio Rodríguez-Crespo, Concepción García, Manuel Guzmán, Eva de Lago y Javier Fernández-Ruiz. "BiP Heterozigosity Aggravates Pathological Deterioration in Experimental Amyotrophic Lateral Sclerosis". International Journal of Molecular Sciences 22, n.º 22 (20 de noviembre de 2021): 12533. http://dx.doi.org/10.3390/ijms222212533.
Texto completoPoojitha, T. N. S., K. V. L. Pushpanjali, D. Goutham, K. V. Yashwanth y Srinivas Prasad. "A study on mutation testing of object oriented programs". International Journal of Engineering & Technology 7, n.º 1.1 (21 de diciembre de 2017): 243. http://dx.doi.org/10.14419/ijet.v7i1.1.9478.
Texto completoDutta, Sayantanee, Gudrun Pregartner, Frank G. Rücker, Ellen Heitzer, Armin Zebisch, Lars Bullinger, Andrea Berghold, Konstanze Döhner y Heinz Sill. "Functional Classification of TP53 Mutations in Acute Myeloid Leukemia". Blood 134, Supplement_1 (13 de noviembre de 2019): 2725. http://dx.doi.org/10.1182/blood-2019-124316.
Texto completoYabe, Mariko, Aidana Z. Omarbekova, Meier Hsu, Hannah May, Maria E. Arcila, Ying Liu, Ahmet Dogan et al. "TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes". Cancers 13, n.º 21 (2 de noviembre de 2021): 5502. http://dx.doi.org/10.3390/cancers13215502.
Texto completoWu, Dongping, Lingjuan Huang, Jiwei Mao, Jianjiang Liu, Wanli Ye, Jun Xu, Wangyan Zhong, Xiaoyu Zhang y Shenpeng Ying. "Combination of Tumor Mutational Burden and DNA Damage Repair Gene Mutations with Stromal/Immune Scores Improved Prognosis Stratification in Patients with Lung Adenocarcinoma". Journal of Oncology 2022 (20 de septiembre de 2022): 1–12. http://dx.doi.org/10.1155/2022/6407344.
Texto completoKulkarni, Aditya, Jianli Zhou, Kishor Bhatia y Panna Sharma. "Tumor sensitization to PARP inhibitors by DNA damaging synthetically lethal acylfulvenes." Journal of Clinical Oncology 41, n.º 16_suppl (1 de junio de 2023): e15123-e15123. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e15123.
Texto completoDeCuypere, Michael, Melissa LoPresti, Hinda Najem, Shashwat Tripathi, Joanne Xiu, Hilary Seifert, Valerie I. Brown et al. "Vulnerability to immune therapy in BRAF- and MYB-altered pediatric gliomas." Journal of Clinical Oncology 41, n.º 16_suppl (1 de junio de 2023): 2066. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.2066.
Texto completoJamshidi, Pouya, Kristyn Galbraith, Matthew Mccord, Lucas Santana-Santos, Lawrence Jennings, Matija Snuderl y Craig Horbinski. "PATH-44. VARIANT ALLELIC FREQUENCY OF DRIVER MUTATIONS PREDICTS SUCCESS OF GENOMIC METHYLATION CLASSIFICATION IN CNS TUMORS". Neuro-Oncology 24, Supplement_7 (1 de noviembre de 2022): vii160. http://dx.doi.org/10.1093/neuonc/noac209.617.
Texto completoDeStefanis, Rebecca A., Autumn M. Olson, Alyssa K. DeZeeuw, Susan N. Payne, Cheri A. Pasch, Linda Clipson y Dustin A. Deming. "Abstract 1128: MTORC1/2 and HDAC1/2 inhibition promote tumor response through inhibition of MYC". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 1128. http://dx.doi.org/10.1158/1538-7445.am2022-1128.
Texto completoArsyad, Nur Rohmah, Risanto Siswosudarmo y Ardhanu Kusumanto. "Hubungan antara Ekspresi P53 Mutan terhadap Operabilitas Kanker Serviks Stadium IIB Pasca Kemoterapi Neoajuvan". Jurnal Kesehatan Reproduksi 7, n.º 1 (14 de mayo de 2020): 49. http://dx.doi.org/10.22146/jkr.53838.
Texto completo